Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
24/02/2026
Thai finance minister: plans to enact comprehensive laws to attract investment.
Latest
3 m ago
Novo Nordisk: UBT251 appears to have safe and well-tolerated characteristics, consistent with intestine-promoting insulin-based therapy.
3 m ago
Noh and Nod: The triple stimulant UBT251 achieved an average weight loss of up to 19.7% after 24 weeks in Phase 2 clinical trials in China.
4 m ago
Tongde Chemicals: Received the "Notice of Implementation" and "Implementation Ruling" and had bank deposits in the amount of RMB 53.92 million frozen and deducted.
4 m ago
Hengrui Pharmaceuticals: Class 1 innovative drug SHR-1918 injection has been accepted for review and included in the priority review program.
4 m ago
Hechuan Technology: Shareholders holding more than 5% of the shares have completed the reduction plan, and only reduced 200 shares.
See all latest